로딩 중…
지수 로딩 중…
Evolus, Inc.
EOLS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$6.63-1.63%
2026-06-18
Price Chart
Evolus, Inc.-28.71%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $437M |
| Revenue | $302M |
| Net Income | $-43M |
| Total Assets | $221M |
| Net Assets | $19M |
| Value | |
| P/B | 22.61x |
| P/S | 1.45x |
| FCF Yield | -9.46% |
| Profitability | |
| ROA | -19.68% |
| Op. Margin | -9.56% |
| Revenue Growth | 6.74% |
| Financial Health | |
| Debt Ratio | 1291.43% |
| Total Debt | $165M |
| FCF | $-41M |
| Cash | $50M |
| Current Ratio | 2.04x |
| Performance | |
| 1Y Return | -28.71% |
| 1M Return | 3.11% |
| From 52W High | -35.00% |
| 1Y MDD | -67.76% |
| Trading | |
| Volume | 1,060,816 shares |
| Trading Value | $7M |
| Per Share | |
| EPS | $-0.80 |